Novartis Oncology Software Engineering Manager Salaries in Baltimore, MD
The average Novartis Oncology Software Engineering Manager in Baltimore, MD earns an estimated $137,830 annually, which includes an estimated base salary of $122,830 with a $15,000 bonus. Novartis Oncology's Software Engineering Manager compensation is $21,750 less than the US average for a Software Engineering Manager. Software Engineering Manager salaries at Novartis Oncology in Baltimore, MD can range from $98,000 - $144,800.
In Baltimore, MD, The Engineering Department at Novartis Oncology earns $704 more on average than the Design Department.
Last updated 3 years ago.
- $122,830
- avg. base
- $15,000
- avg. bonus
Software Engineering Manager Salaries at Novartis Oncology
In Baltimore, MD, Software Engineering Managers earn $512 more than Principal Engineers, and $26,208 less than Group Engineering Managers.
Compensation at Novartis Oncology by Department
In Baltimore, MD, The Engineering Department averages $704 more than the Design Department, and $6,414 less than the HR Department
Software Engineering Manager Compensation by Gender (All Companies)
The average female Software Engineering Manager at companies similar size to Novartis Oncology reported making $164,584, while the average male Software Engineering Manager at similar sized companies reported making $184,820.
Software Engineering Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Software Engineering Manager at companies similar size to Novartis Oncology reported making $191,271, while the average Native American Software Engineering Manager at similar sized companies reported making $155,000.
How Software Engineering Managers at Novartis Oncology Rate Their Compensation
The majority of Software Engineering Managers at Novartis Oncology believe they're not compensated fairly. 100% of Software Engineering Managers at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
